skin PA 7

download skin PA 7

of 61

Transcript of skin PA 7

  • 7/27/2019 skin PA 7

    1/61

    SKIN PATHOLOGY

    EDITED BY

    Dr. JUSUF FANTONI SpPA,MScPath (Glasg)

  • 7/27/2019 skin PA 7

    2/61

    Epidemiology

    Most common human cancer

    600,000 to 800,000 cases per year in U.S.

    Male:Female 2-3:1

    80% arise in head and neck

    SCCa over 60 years old

    BCCa over 40 years old

  • 7/27/2019 skin PA 7

    3/61

    Etiology

    Ultraviolet radiation

    ethnicity

    ionizing radiation exposure

    chemical exposure - arsenic

    burns, scarring

    immunosuppression

  • 7/27/2019 skin PA 7

    4/61

    Syndromes

    Xeroderma pigmentosum

    nevoid basal cell syndrome

    albinism

    epidermodysplastic verrucoformis

    epidermolysis bullosa dystrophica

    dyskeratosis congenital

  • 7/27/2019 skin PA 7

    5/61

    Skin

    Largest organ

    major functions

    protection

    sensation

    thermoregulation

    metabolic

  • 7/27/2019 skin PA 7

    6/61

    Skin structure

    Epidermis

    dermis

    hypodermis

    epidermal appendages

  • 7/27/2019 skin PA 7

    7/61

    Skin Histology

    Stratum corneum

    stratum lucidum

    stratum granulosum

    stratum spinosum stratum basale

  • 7/27/2019 skin PA 7

    8/61

    VITILIGO

    Vitiligo is a common disorder characterized by partial

    or complete loss of pigment producing melanocytes within

    the epidermis.All ages and races are affected, but lesions are most

    noticeable in darkly pigmented individuals.

    Clinical lesions are asymptomatic, flat, well-

    demarcated macules and patches of pigment loss; their

    size varies from few to many cnetimeters. Vitiligo ofteninvolves the hands and wrists, axillae and perioral;

    periorbital and anogenital skin

    DISORDERS OF PIGMENTATION and MELANOCYTES

  • 7/27/2019 skin PA 7

    9/61

  • 7/27/2019 skin PA 7

    10/61

    Melanocytic Nevus ( Pigmented Nevus, Mole )Most of us have at least a few moles. Clinically, common

    acquired melanocytic nevi are tan to brown, uniformly pigmented,

    small ( usally < 6 mm across), flat (macules) to elevated ( papules )

    with well-defined rounded borders.

    Morphology.

    Melanocytic nevi are initially formed by melanocytes that have

    been transformed from highly dendritic single cells normally

    intersperesed among basal keratinocytes to round cells that grow inaggregates, or nests. along the dermoepidermal junction. Nuclei of

    nevus cells are uniform and rounded in contour, contain inconspicuous

    nucleoli, and show little or no mitotic activity. Such lesions are believed

    to represent an early developmental stage in melanocytic nevi and are

    called Junc t ional nev i.

  • 7/27/2019 skin PA 7

    11/61

    Eventually, most junctional nevi grow into the underlying dermisas nests or cords of cells ( Compound nev i ); in older lesions, the

    epidermal nests may be lost entirely to form pure Intradermal nevi.

    Clinically, compound and dermal nevi are often more elevated than

    junctional nevi.

    Progressive growth of nevus cells from the dermoepidermal

    junction into the underlying dermis is accompanied by a process

    termed maturation. Less mature, more superficial nevus cells are

    larger, tend to produce melanin, and grow in nests; more mature,

    deeper nevus cells are smaller, produce little or no pigment and grow

    in cords. The most mature nevus cells may be found at the deepest

    extent of lesions where they often acquire fusiform contours and grow

    in fascicl;es resembling neural tissue.

  • 7/27/2019 skin PA 7

    12/61

  • 7/27/2019 skin PA 7

    13/61

    Clinical Features.Malignant melanoma of the skin is ususally asymptomatic,

    although itching may be an early manifestation. The majority of

    lesions are greater than 10 mm. The most important clinical sign ofthe disease is change in color, size, or shape in a pigmented

    lesion.

    On occasion, zones of white or flesh-colored hypopigmentation are

    also present. The clinical warning signs of melanoma are : (1)

    enalrgement of a pre-existing mole, (2) itching or pain, (3)

    development of a new pigmented lesion during adult life, (4)

    irregularity of the borders, (5) variegation of color within a pigmented

    lesion.

    Growth Patterns and Morphology

    Simply stated, radial growth indicates the tnedency of amelanoma to grow horizontally within the epidermal and superficial

    dermal layers, often for a prolonged time. During this stage of

    growth, melanoma cells do not have the capacity to metastasize., i.e.

    Lentigo maligna, superficial spreading and acral / mucosal lentiginous.

  • 7/27/2019 skin PA 7

    14/61

    Individual melanoma cells are usually larger than nevuscells. They contain large nuclei with irregular contours and prominent

    nucleoli. These cells proliferate as poorly formed nests or as

    individual cells at all levels of the epidermisThe nature and extent of the vertical growth phase

    determine the biologic behaviour of malignant melanoma.

    Benign Epithelial Tumors

    Seborrheic Keratosis

    Occur frequently in middle-aged or older

    individuals. They arise spontaneously and may become

    numerous on the trunk; also the extremities, head, and neck

    may also be involved.

  • 7/27/2019 skin PA 7

    15/61

    They appear as round, flat, coinlike, waxy plaques thatvary in diameter from mm to several cms. They are

    uniformly tan to dark brown and show a velvety to granular

    surface.

    Morphology

    Exophytic and demarcated sharply from the adjacent

    epidermis. They are composed of sheets of small cells that most

    resemble basal cells of the normal epidermis. Variable melaninpigmentation is present within these basaloid cells. Exuberant

    keratin production (hyperkeratosis occurs) and small keratin-filled

    cysts (horn cysts ) and invaginations of keratin into the main tumor

    mass ( invagination cysts ) are characteristic

    features. Interestingly, when seborrheic keratoses become irritated

    and inflamed, they undergo squamous differentiation and

    characterized by foci of whorling squamous cells resembling

    eddy currents in a stream. When sborrheic keratoses involve the

    epithelium of hair follicles, they may grow in an endophytic (

    downward) fashion, and show the effects of inflammation; such

    lesions are termed : Inverted fol l icular keratoses

  • 7/27/2019 skin PA 7

    16/61

  • 7/27/2019 skin PA 7

    17/61

  • 7/27/2019 skin PA 7

    18/61

  • 7/27/2019 skin PA 7

    19/61

    = slow-growing tumors that rarely metastasize.

    Tendency to occur at sites of chronic sun exposure and in

    lightly pigmented people. B C C rises sharply with

    immunsuppresion and in patients with inherited defects in

    DNA repair.

    Clinically, as pearly papules often containing

    prominent, dilated subepidermal blood vessels (

    telangiectasias ). Some contain melanin. Advanced lesionsmay ulcerate, extensive local invasion of bone or facial

    sinuses may occur after many years of neglect (=rodent

    ulcers )

    Basal Cell Carcinoma ( B C C )

  • 7/27/2019 skin PA 7

    20/61

    Tumor cells resemble those in the normal basal cell

    layer of the epidermis. They arise from the epidermis or follicular

    epithelium and do not occur on mucosal surfaces. Two patterns

    are seen :mu l t ifocal grow ths originating from the epidermis and

    extending over several square cmsor more fo skin surface and

    nodular lesions growing downward deeply into the dermis ascords and islands of variably basophilic cells with hyperchromatic

    nuclei, embedded in a mucinous matrix, and often surrounded by

    many fibroblasts and lymphocytes. The cells forming the periphery

    of the tumor cell islands tend to be arranged in approximately

    parallel alignment ( palisading )

    The stroma shrinks away from the epithelial tumor

    nests, creating clefts or separation artifacts that assist in

    differentiating basal cell carcinomas from certain appendage tumors

    also characterized by proliferation of basaloid cells ( e.g.

    trichoepithelioma )/.

    Morphology

  • 7/27/2019 skin PA 7

    21/61

  • 7/27/2019 skin PA 7

    22/61

    Actinic Keratosis

  • 7/27/2019 skin PA 7

    23/61

    Keratoacanthoma

    Solitary or multiple

    rapid growth

    1 to 2.5 cm

    ulcer with keratinousmaterial

    spontaneous resolution

    observe, 5-FU, Mohs'

  • 7/27/2019 skin PA 7

    24/61

  • 7/27/2019 skin PA 7

    25/61

  • 7/27/2019 skin PA 7

    26/61

  • 7/27/2019 skin PA 7

    27/61

    Basal Cell Carcinoma

    Raised, with pearly

    border

    prominent vasculature

    ulceration

    nodular most common

  • 7/27/2019 skin PA 7

    28/61

    Pigmented Basal Cell

    Produce brown pigment

    often mistaken for

    melanoma

    behave similar to

    nodular

  • 7/27/2019 skin PA 7

    29/61

    Superficial Basal Cell

    Scaly patches

    irregular borders

    extremities, less

    common in head and

    neck

  • 7/27/2019 skin PA 7

    30/61

  • 7/27/2019 skin PA 7

    31/61

  • 7/27/2019 skin PA 7

    32/61

  • 7/27/2019 skin PA 7

    33/61

  • 7/27/2019 skin PA 7

    34/61

  • 7/27/2019 skin PA 7

    35/61

    Adenoid Basal Cell

    Pseudo-glandular

    formation

    strands of epithelial

    cells in lace-like

    patterns

  • 7/27/2019 skin PA 7

    36/61

    Basal Cell Biologic Behavior

    Dependent upon stroma

    locally invasive

    spread along resistant planes

    metastasis rare - 0.0028% to 0.1%

    adenoid and keratotic types more likely

  • 7/27/2019 skin PA 7

    37/61

    Basal Cell Biologic Behavior

    Embryonic fusion planes at risk for deep

    invasion

    inner canthus

    philtrum chin

    nasolabial groove

    pre-auricular

    retro-auricular sulcus

  • 7/27/2019 skin PA 7

    38/61

    Squamous Cell Carcinoma

    Sun exposure

    erythematous,

    ulcerated, crusting

    friable

    adjacent induration

    actinic vs. de novo

  • 7/27/2019 skin PA 7

    39/61

    Squamous Cell Metastasis

    Actinic lesions 3% to

    5%

    de novo 8%

    scar or chronic

    inflammation 10% to

    30%

    deep invasion

    higher grade

    perineural invasion

  • 7/27/2019 skin PA 7

    40/61

    Squamous Cell Histopathology

    Well, moderate and poorly differentiated

    generic

    adenoid

    bowenoid

    verrucous

    spindle cell or pleomorphic

  • 7/27/2019 skin PA 7

    41/61

    Squamous Cell Histopathology

  • 7/27/2019 skin PA 7

    42/61

    Adenoid Squamous Cell

    Pseudoglandular

    arrangement

    dyskeratosis

    acantholysis

    periauricular

  • 7/27/2019 skin PA 7

    43/61

    Verrucous Squamous Cell

    Rare on skin

    cauliflower-like

    well-differentiated

    marked hyperkeratosis,parakeratosis,

    acanthosis

    invasion with pushing

    margins

  • 7/27/2019 skin PA 7

    44/61

  • 7/27/2019 skin PA 7

    45/61

    Staging

  • 7/27/2019 skin PA 7

    46/61

  • 7/27/2019 skin PA 7

    47/61

  • 7/27/2019 skin PA 7

    48/61

    Treatment - Excision

    Most often used by head & neck surgeons

    93% to 95% cure

    advantages

    specimen for evaluation

    control of margins (3 to 5 mm)

    disadvantages

    expensive time-consuming

  • 7/27/2019 skin PA 7

    49/61

    Treatment - Laser

    Patients with medical diseases

    multiple lesions

    palliation

  • 7/27/2019 skin PA 7

    50/61

    Treatment - Mohs Surgery

    96% to 99% cure

  • 7/27/2019 skin PA 7

    51/61

    Treatment - Radiation

    Prolonged course

    radiodermatitis

    carcinogenesis

    useful in poor surgical patients

    no control of margins

    recurrence in 4.4% to 9.5%

    T t t Ph t d i

  • 7/27/2019 skin PA 7

    52/61

    Treatment - Photodynamic

    Therapy

    Photosensitive drug concentrated in tumor

    porphyrin, argon ion dye pump laser most

    common

    still experimental

  • 7/27/2019 skin PA 7

    53/61

    Treatment - Interferon

    Interferon -

    low dose, intralesional

    3 times a week

    flu-like illness

    erythema, pain

    stimulation of macrophages and NK cells

  • 7/27/2019 skin PA 7

    54/61

    Treatment - Chemotherapy

    Retinoids

    cis-platin - most widely used

    bleomycin

    cyclophosphamide

    5-fluorouracil

    vinblastine

  • 7/27/2019 skin PA 7

    55/61

  • 7/27/2019 skin PA 7

    56/61

    Treatment - Regional Lymphatics

    Parotidectomy for

    periauricular tumors

    spare uninvolved

    structures

    post op XRT as

    indicated

  • 7/27/2019 skin PA 7

    57/61

    Treatment - Selection

  • 7/27/2019 skin PA 7

    58/61

    Recurrence

    BCCa 1-39%

    Nodular 1-6%

    Morpheaform 12-30%

    3 years

    SCCa variable

    recurrence rates

    75% of recurrences

    occur within 2 years

    95% of recurrencesoccur within 5 years

  • 7/27/2019 skin PA 7

    59/61

  • 7/27/2019 skin PA 7

    60/61

    Mortality

    Exact numbers not available - not consistently

    reported

    0.44 per 100,000 persons per year

    2,000 to 3,000 deaths per year in U.S. patients 65-70 years old

    widespread SCCa arising in periauricular

    region

  • 7/27/2019 skin PA 7

    61/61

    Conclusion

    Common tumors

    best chance for cure is early diagnosis and

    treatment

    prevent new lesions with sun protection